Sentinel Initiative Public Workshop - Eighth Annual

Project Title Sentinel Initiative Public Workshop - Eighth Annual
Date
Tuesday, February 2, 2016
Host

Mark McClellan, MD, PhD, Duke-Robert J. Margolis Center for Health Policy and Robert J. Margolis Professor of Business, Medicine and Health Policy, Duke University; Greg Daniel, PhD, MPH, Deputy Director, Duke-Robert J. Margolis Center for Health Policy and Clinical Professor, Fuqua School of Business, Duke University

Location
Presenters

Steven Anderson, PhD, MPP, Director, Office of Biostatistics and Epidemiology, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration; Kathleen Blake, MD, MPH, Vice President, Performance Improvement, American Medical Association; Jeff Brown, PhD, Associate Professor, Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute; Patrizia A. Cavazzoni, MD, Senior Vice President, Worldwide Development Operations, Pfizer, Inc.; Francesca Cunningham, PharmD, Associate Chief Consultant, Medication Safety, PBM, and Director, Center for Medication Safety, U.S. Department of Veterans Affairs; Gerald J. Dal Pan, MD, MHS, Director, Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration; Bruce Fireman, Biostatistician, Division of Research, Kaiser Permanente Northern California; Susan Hariri, PhD, Scientific Deputy, Prevention Branch, Division of Viral Hepatitis, U.S. Centers for Disease Control and Prevention; Troy McCall, PhD, Chief Implementation Officer, Reagan-Udall Foundation for the FDA; Catherine M. Meyers, MD, Director, Office of Clinical and Regulatory Affairs, National Center for Complementary and Integrative Health, National Institutes of Health; J. Stephen Mikita, JD, Planning Board Member, Sentinel, Lead, Sentinel Engagement Partners Workgroup, Patient Representative, Duke Clinical Trials Transformation Initiative; Gregory Pappas, MD, PhD, Associate Director for National Device Surveillance, Office of Surveillance and Biometrics, Center for Devices and Radiological Health, U.S. Food and Drug Administration; Doris Peter, PhD, Director, Health Ratings Center, Consumer Reports; Richard Platt, MD, MSc, Professor and Chair, Department of Population Medicine, Harvard Medical School, Executive Director, Harvard Pilgrim Health Care Institute; Marsha E. Reichman, PhD, Senior Advisor and Scientific Lead for Surveillance Programs, Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration; Commander (CDR) Melissa Robb, Associate Director for Regulatory Affairs, Office of Medical Policy, Center for Drug Evaluation and Research, U.S. Food and Drug Administration; Joe Selby, MD, MPH, Executive Director, Patient-Centered Outcomes Research Institute; Azadeh Shoaibi, PhD, MHS, Sentinel Lead, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration; Paul Wallace, MD, Chief Medical Officer and Senior Vice President, Clinical Translation, Optum Labs; Janet Woodcock, MD, Director, Center for Drug Evaluation and Research, U.S. Food and Drug Administration.